Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective
Clinical trial NCT02504476 · COMPLETED
Trial details
- NCT number
- NCT02504476
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-02-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.